Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Itraconazole in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
- Status
- COMPLETED
- Phase
- PHASE3
A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC
- Status
- TERMINATED
- Phase
- PHASE1
Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Powered Surgical Stapler in VATS Lung Resection Procedures in China
- Status
- COMPLETED
- Phase
- N/A
Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- N/A
TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE3
An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).
- Status
- COMPLETED
- Phase
- N/A
Immune Boost In Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- NA
A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label
- Status
- TERMINATED
- Phase
- PHASE2
Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity
- Status
- COMPLETED
- Phase
- PHASE2
A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain
- Status
- COMPLETED
- Phase
- PHASE2